SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041382
Filing Date
2023-08-10
Accepted
2023-08-10 16:27:15
Documents
61
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tyra-20230630.htm   iXBRL 10-Q 1930676
2 EX-31.1 tyra-ex31_1.htm EX-31.1 21236
3 EX-31.2 tyra-ex31_2.htm EX-31.2 21466
4 EX-32.1 tyra-ex32_1.htm EX-32.1 11838
5 EX-32.2 tyra-ex32_2.htm EX-32.2 11801
  Complete submission text file 0000950170-23-041382.txt   6969111

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tyra-20230630_cal.xml EX-101.CAL 31432
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tyra-20230630_lab.xml EX-101.LAB 336010
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tyra-20230630_def.xml EX-101.DEF 126410
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tyra-20230630_pre.xml EX-101.PRE 242331
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tyra-20230630.xsd EX-101.SCH 43185
55 EXTRACTED XBRL INSTANCE DOCUMENT tyra-20230630_htm.xml XML 1403885
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

IRS No.: 831476348 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40800 | Film No.: 231159955
SIC: 2834 Pharmaceutical Preparations